{
  "id": "mhgap#management_b0ef61ab",
  "content": "Dayanand Medical College,\nLudhiana, India\nMs Sahar Vasquez Mind Health Connect, Belize Americas Lived experience, advocacy\nCity, Belize\nProfessor Min Zhao Shanghai Drug Abuse Western Pacific Substance use disorders\nTreatment Center treatment and prevention,\nmental health and addiction\nShanghai Mental\nHealth Center\nShanghai Jiaotong University\nSchool of Medicine\nShanghai, China\n142\nAnnex 1. Contributors to the guideline\nMembers of the evidence review and synthesis teams\nRoberta Agabio, University of Cagliari, Cagliari, Italy\nAemal Akhtar, Karolinska Institutet, Stockholm, Sweden\nSatinder Aneja, Sharda Hospital, Sharda University, Noida, India\nArpana Amarnath, Vrije Universiteit Amsterdam, Amsterdam, Netherlands (Kingdom of the)\nIoannis Angelakis, University of Liverpool, Liverpool, United Kingdom\nFelipe Branco Arcadepani, Universidade Federal de São Paulo, São Paulo, Brazil\nAbdullah Arjmand, Phoenix Australia, University of Melbourne, Melbourne, Australia\nBiksegn Asrat, University of Gondar, Gondar, Ethiopia\nIrene Bighelli, Technical University of Munich, Munich, Germany\nAdam Bisaga, Columbia University, New York, USA\nNiko Boumparis, Swiss Research Institute for Public Health and Addiction, Zurich, Switzerland\nMiles Brown, University of Exeter, Exeter, United Kingdom\nTanya Calvey, University of Cape Town, Cape Town, South Africa\nAntonella Camposeragna, Lazio Regional Health Service, Rome, Italy\nMarketa Ciharova, Vrije Universiteit Amsterdam, Amsterdam, Netherlands (Kingdom of the)",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Management Dayanand Medical College,\nLudhiana, India\nMs Sahar Vasquez Mind Health Connect, Belize Americas Lived experience, advocacy\nCity, Belize\nProfessor Min Zhao Shanghai Drug Abuse Western Pacific Substance use disorders\nTreatment Center treatment and prevention,\nmental health and addiction\nShanghai Mental\nHealth Center\nShanghai Jiaotong University\nSchool of Medicine\nShanghai, China\n142\nAnnex 1. Contributors to the guideline\nMembers of the evidence review and synthesis teams\nRoberta Agabio, University of Cagliari, Cagliari, Italy\nAemal Akhtar, Karolinska Institutet, Stockholm, Sweden\nSatinder Aneja, Sharda Hospital, Sharda University, Noida, India\nArpana Amarnath, Vrije Universiteit Amsterdam, Amsterdam, Netherlands (Kingdom of the)\nIoannis Angelakis, University of Liverpool, Liverpool, United Kingdom\nFelipe Branco Arcadepani, Universidade Federal de São Paulo, São Paulo, Brazil\nAbdullah Arjmand, Phoenix Australia, University of Melbourne, Melbourne, Australia\nBiksegn Asrat, University of Gondar, Gondar, Ethiopia\nIrene Bighelli, Technical University of Munich, Munich, Germany\nAdam Bisaga, Columbia University, New York, USA\nNiko Boumparis, Swiss Research Institute for Public Health and Addiction, Zurich, Switzerland\nMiles Brown, University of Exeter, Exeter, United Kingdom\nTanya Calvey, University of Cape Town, Cape Town, South Africa\nAntonella Camposeragna, Lazio Regional Health Service, Rome, Italy\nMarketa Ciharova, Vrije Universiteit Amsterdam, Amsterdam, Netherlands (Kingdom of the) Dayanand medical college,\nludhiana, india\nms sahar vasquez mind health connect, belize americas lived experience, advocacy\ncity, belize\nprofessor min zhao shanghai drug abuse western pacific substance use disorders\ntreat..."
}